Fortis to finally report its Q4 numbers today. Here#39;s what to expect
Fortis is going through a severe cash crunch at the moment. The company#39;s debt was downgraded by rating agencies and borrowing more money hasn#39;t been easy
Latest News from Moneycontrol.com
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




